StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) stock

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$1.19−0.12 (-9.16%)

Close on Nov 12, 2026Market cap $20.93MP/E –Yield –

Earnings

Cel Sci's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cel Sci's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cel Sci has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cel Sci puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cel Sci filed with the SEC as exhibits to Form 8-K or 6-K

  1. PRESS RELEASE DATED JUNE 14, 2026
    News
  2. PRESS RELEASE DATED JUNE 16, 2026
    News
  3. 8-K exhibit EX-99.1
    News
  4. 8-K exhibit EX-99.2
    News
  5. 8-K exhibit EX-99.1
    News
  6. 8-K exhibit EX-99.2
    News
  7. 8-K exhibit EX-99.1
    News
  8. 8-K exhibit EX-99.2
    News
  9. 8-K exhibit EX-99.1
    News
  10. 8-K exhibit EX-99.2
    News
  11. 8-K exhibit EX-99.1
    News
  12. 8-K exhibit EX-99.2
    News
  13. 8-K exhibit EX-99.1
    News
  14. 8-K exhibit EX-99.2
    News
  15. 8-K exhibit EX-99
    News

See a number that looks wrong?